Vineeta Singh specializes in the treatment of patients with stroke, brain and spinal cord injury, encephalopathy, and status epilepticus. She earned her medical degree at Banaras Hindu University in India, where she also completed a medicine residency. Dr. Singh completed a residency in neurology at Allegheny University Hospital in Philadelphia, and a fellowship in Stroke and Neurocritical Care at UCSF Medical Center before joining the medical center staff in 2000 as an active clinician, educator, and researcher. She is board certified in Adult Neurology, Vascular Neurology and Neurocritical Care.
Since 2007, she has been based at San Francisco General Hospital, a Level 1 Trauma Center, caring for patients with life-threatening neurologic disorders in the surgical/trauma ICU. She enjoys the challenge of ensuring that underserved patients with a broad spectrum of primary disorders of the nervous system or neurologic complications of trauma and major systemic illness receive high quality care.
From 2006-11, Dr. Singh directed the UCSF Neurocritical Care Fellowship Program, which was accredited by the UCNS in 2008. She is actively involved in resident and student teaching and was recognized by the UCSF Academy of Medical Educators for Excellence in Direct Teaching in 2012.
Dr. Singh is a recipient of career development award from NIH/NINDS that supported her research on Dural Arteriovenous Fistulas. She has been involved in a number of multicenter human clinical trials of stroke as co-investigator since 1999 and is currently the site-PI for NIH-funded Intracerebral hemorrhage Deferoxamine trial. Dr. Singh is member of several national and international professional societies and a Fellow of American Academy of Neurology, American Neurological Association and American Heart Association.